Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
68.00    0.60 (0.89%)
Bid:
67.80
Ask:
67.90
Spread: 0.10 (0.147%)
Market Cap: £600.73m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Further re Scrip Dividend

29 Jun 2022 09:16

RNS Number : 6180Q
IP Group PLC
29 June 2022
 

FOR RELEASE ON

29 June 2022

 

IP Group plc - Further re Scrip Dividend

 

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces that further to the announcement made on 06 June 2022 in relation to the Scrip Dividend, the Group has received valid elections from certain shareholders. IP Group intends to sell Ordinary Shares which are currently held in treasury to satisfy such elections and will transfer these shares pursuant to the Scrip Dividend Terms and Conditions ("the Scrip Dividend Shares"). 

 

330,851 Scrip Dividend Shares will be transferred to relevant shareholders on 30 June 2022. Following such transfer, and in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Group will have 1,063,033,287 Ordinary Shares in issue and 28,607,622 shares in Treasury.

 

The total number of Ordinary Shares with voting rights following the satisfaction of the transfer will be 1,034,425,665 Ordinary Shares. This figure may be used by shareholders in the Group as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURMZGZVRLMGZZG
Date   Source Headline
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
13th May 20255:30 pmRNSTransaction in Own Shares
12th May 20256:03 pmRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
8th May 20256:25 pmRNSTransaction in Own Shares
7th May 20255:00 pmRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
2nd May 20255:27 pmRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20251:21 pmRNSDirector/PDMR Shareholding
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20254:59 pmRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 202511:41 amRNSResult of Meeting
23rd Apr 20255:09 pmRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20255:39 pmRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20255:04 pmRNSNotice of AGM
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSDirector/PDMR Shareholding
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20256:08 pmRNSTransaction in Own Shares
3rd Apr 20255:55 pmRNSTransaction in Own Shares
2nd Apr 20256:10 pmRNSTransaction in Own Shares
1st Apr 20255:25 pmRNSTransaction in Own Shares
31st Mar 20255:33 pmRNSTotal Voting Rights
31st Mar 20255:31 pmRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20253:42 pmRNSHolding(s) in Company
27th Mar 20256:07 pmRNSTransaction in Own Shares
26th Mar 20255:34 pmRNSTransaction in Own Shares
26th Mar 20254:38 pmRNSHolding(s) in Company
26th Mar 202511:53 amRNSHolding(s) in Company
26th Mar 202511:13 amRNSHolding(s) in Company
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNS2024 Annual Results
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20256:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.